BibTex RIS Cite

Radyasyon Miyelopatisi: Olgu Sunumu

Year 2005, Volume: 22 Issue: 1, 46 - 49, 31.12.2009

Abstract

Miyelopati, radyoterapinin ender görülen bir komplikasyonudur. Radyasyon miyelopatisi, iyonizan radyasyon ile karşılaşıldıktan belli bir süre sonra spinal kordun beyaz cevher hasarı ile gelişir. Radyasyon dozu, uygulamalar arasındaki süre veya lineer enerji transferi gibi bazı faktörler miyelopatinin oluşumunu ve şiddetini etkiler. Bu olgu sunumunda, mide adenokarsinomu tanısıyla yapılan operasyondan sonra kemoterapi ve radyoterapi uygulanan 56 yaşındaki erkek hastada, iki ay sonra gelişen ilerleyici paraparezi bildirilmektedir.Bu olgu, radyoterapi tedavisi sonrası nörolojik disfonksiyon gelişen hastalara örnektir.


Radiation Myelopathy: Case Report

Myelopathy is an uncommon complication of radiotherapy. Radiation myelopathy is principally a white matter injury of the spinal cord induced by ionizing radiation after a certain latent period. Several factors, such as radiation dose, fractination or linear energy transfer, modify its occurrence and severity. A 56-year old man with gastric adenocarcinoma underwent chemotherapy and radiotherapy following tumor excision. Two months later he developed a progressive paraparesis. This case is a model for the patiens that develops neurologic dysfunction after radiotherapy.

References

  • Antunes NL, Wolden S, Souweidane MM et al. Radiation myelitis in a 5–year–old girl. J Child Neurol 2002 Mar; 17: 217–219.
  • Maranzano E, Bellavita R, Floridi P et al. Radiation–induced myelopathy in long–term surviving metastatic spinal cord compression patients after hypofractionated radiotherapy: a clinical and magnetic resonance imaging analysis. Radiother Oncol 2001 Sep; 60: 281–288.
  • Okada S, Okeda R. Pathology of radiation myelopathy. Neuropathology 2001 Dec; 21: 247–265.
  • Micheal WT,Andrew W, Gail R et al. Radiation myelopathy following transplantation and radioterapy for Non–Hoodgkin’s Lymphoma. Int .J. Radiation Oncology 1998 Mar; 41: 1057–1061.
  • Toshihiro Y, Hisatoshi Y, Masaki K et al. Significance of gadolinium–enchanced magnetic resonance imaging in differentiating spinal cord radiation myelopathy from tumor: case report. J Neurosurg 1992 Oct; 77: 628–631.
  • Richard HF, Richard DM, Keene MW. Chronic Radiation Myelitis. Radiology 1982 Aug; 144: 609–612.
  • Philips TL, Buschke F. Radiation tolerance of the tho- racic spinal cord. AJR 1969; 105: 659–664.
Year 2005, Volume: 22 Issue: 1, 46 - 49, 31.12.2009

Abstract

References

  • Antunes NL, Wolden S, Souweidane MM et al. Radiation myelitis in a 5–year–old girl. J Child Neurol 2002 Mar; 17: 217–219.
  • Maranzano E, Bellavita R, Floridi P et al. Radiation–induced myelopathy in long–term surviving metastatic spinal cord compression patients after hypofractionated radiotherapy: a clinical and magnetic resonance imaging analysis. Radiother Oncol 2001 Sep; 60: 281–288.
  • Okada S, Okeda R. Pathology of radiation myelopathy. Neuropathology 2001 Dec; 21: 247–265.
  • Micheal WT,Andrew W, Gail R et al. Radiation myelopathy following transplantation and radioterapy for Non–Hoodgkin’s Lymphoma. Int .J. Radiation Oncology 1998 Mar; 41: 1057–1061.
  • Toshihiro Y, Hisatoshi Y, Masaki K et al. Significance of gadolinium–enchanced magnetic resonance imaging in differentiating spinal cord radiation myelopathy from tumor: case report. J Neurosurg 1992 Oct; 77: 628–631.
  • Richard HF, Richard DM, Keene MW. Chronic Radiation Myelitis. Radiology 1982 Aug; 144: 609–612.
  • Philips TL, Buschke F. Radiation tolerance of the tho- racic spinal cord. AJR 1969; 105: 659–664.
There are 7 citations in total.

Details

Primary Language English
Journal Section Basic Medical Sciences
Authors

Dr. M. Terzi, This is me

Dr. N. Cengiz This is me

Dr. T. Özbenli This is me

Dr. M.k. Onar This is me

Publication Date December 31, 2009
Submission Date October 28, 2009
Published in Issue Year 2005 Volume: 22 Issue: 1

Cite

APA Terzi, D. M., Cengiz, D. N., Özbenli, D. T., Onar, D. M. (2009). Radyasyon Miyelopatisi: Olgu Sunumu. Journal of Experimental and Clinical Medicine, 22(1), 46-49. https://doi.org/10.5835/jecm.v22i1.85
AMA Terzi, DM, Cengiz DN, Özbenli DT, Onar DM. Radyasyon Miyelopatisi: Olgu Sunumu. J. Exp. Clin. Med. December 2009;22(1):46-49. doi:10.5835/jecm.v22i1.85
Chicago Terzi, Dr. M., Dr. N. Cengiz, Dr. T. Özbenli, and Dr. M.k. Onar. “Radyasyon Miyelopatisi: Olgu Sunumu”. Journal of Experimental and Clinical Medicine 22, no. 1 (December 2009): 46-49. https://doi.org/10.5835/jecm.v22i1.85.
EndNote Terzi, DM, Cengiz DN, Özbenli DT, Onar DM (December 1, 2009) Radyasyon Miyelopatisi: Olgu Sunumu. Journal of Experimental and Clinical Medicine 22 1 46–49.
IEEE D. M. Terzi, D. N. Cengiz, D. T. Özbenli, and D. M. Onar, “Radyasyon Miyelopatisi: Olgu Sunumu”, J. Exp. Clin. Med., vol. 22, no. 1, pp. 46–49, 2009, doi: 10.5835/jecm.v22i1.85.
ISNAD Terzi,, Dr. M. et al. “Radyasyon Miyelopatisi: Olgu Sunumu”. Journal of Experimental and Clinical Medicine 22/1 (December 2009), 46-49. https://doi.org/10.5835/jecm.v22i1.85.
JAMA Terzi, DM, Cengiz DN, Özbenli DT, Onar DM. Radyasyon Miyelopatisi: Olgu Sunumu. J. Exp. Clin. Med. 2009;22:46–49.
MLA Terzi, Dr. M. et al. “Radyasyon Miyelopatisi: Olgu Sunumu”. Journal of Experimental and Clinical Medicine, vol. 22, no. 1, 2009, pp. 46-49, doi:10.5835/jecm.v22i1.85.
Vancouver Terzi, DM, Cengiz DN, Özbenli DT, Onar DM. Radyasyon Miyelopatisi: Olgu Sunumu. J. Exp. Clin. Med. 2009;22(1):46-9.